高级检索

肺癌化疗患者癌因性疲乏变化轨迹及其影响因素的纵向研究

A longitudinal study of the trajectory of cancer-related fatigue in patients with lung cancer chemotherapy and its influencing factors

  • 摘要:
    目的 探讨肺癌化疗患者癌因性疲乏变化轨迹及其影响因素。
    方法 采用前瞻性研究方法,选择2020年12月至2021年12月在复旦大学附属中山医院首次接受化疗的肺癌患者250例,收集患者前6次化疗的化疗前、化疗结束时、化疗结束后1周的癌因性疲乏情况。采用混合增长模型识别患者疲乏轨迹类型,采用logistic回归分析癌因性疲乏的影响因素。
    结果 共识别出6种肺癌患者癌因性疲乏变化轨迹,分别为轻度疲乏稳定型(114例,45.78%)、轻度疲乏缓慢增长型(32例,12.85%)、轻度疲乏高增长型(13例,5.22%)、中度疲乏缓慢增长型(49例,19.68%)、中度疲乏缓解型(17例,6.83%)及高度疲乏缓解型(24例,9.64%)。Logistic回归分析显示,职业、居住方式、家庭人均月收入、医疗负担、咳嗽、吸烟状况、体质指数、呕吐、是否患有合并症、红细胞计数为癌因性疲乏的影响因素(P < 0.05)。
    结论 肺癌化疗患者从首次化疗至6次化疗结束,癌因性疲乏呈现6种发展轨迹,存在个体差异,不同阶段影响因素不同,建议医护人员根据患者不同发展特点及影响因素提供个性化干预措施。

     

    Abstract:
    Objective To explore the trajectory of cancer-related fatigue (CRF) in lung cancer patients undergoing chemotherapy, and the influencing factors.
    Methods Totally, 250 lung cancer patients undergoing chemotherapy in Zhongshan Hospital, Fudan University from December 2020 to December 2021 were prospectively selected, and the CRF was investigated before chemotherapy, at the end of chemotherapy and one week after chemotherapy. A growth hybrid model was used to identify trajectory types of CRF. Logistic regression was used to analyzed the influencing factors of cancer-induced fatigue.
    Results Six different trajectories of CRF were identified: mild fatigue stable type (n=114, 45.78%), mild fatigue slow growth type (n=32, 12.85%), mild fatigue high growth type (n=13, 5.22%), moderate fatigue slow growth type (n=49, 19.68%), moderate fatigue relief type (n=17, 6.83%), and high fatigue relief type (n=24, 9.64%). Logistic regression analysis showed that occupation, living mode, household monthly income per capita, medical burden, cough, smoking status, body mass index (BMI), vomiting, with or without comorbidities, red blood cell count were the influencing factors of CRF (P < 0.05).
    Conclusions There were 6 times of different CRF trajectories in lung cancer patients undergoing chemotherapy from the first chemotherapy to the end of 6 times of chemotherapy, and there were individual differences. The influencing factors of CRF in different treatment periods are different, and personalized interventions should be provided according to the different development characteristics and influencing factors of patients.

     

/

返回文章
返回